Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Parkinson's Disease

Free Subscription 03.11.2025 3 Ann Neurol 1 BMC Neurol 2 Exp Neurol 4 J Neural Transm (Vienna) 10 Mov Disord 1 Neurobiol Dis 1 Neurochem Res 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. JADAPALLI JK, Olson J, Irwin ZT, Nakhmani A, et al
   Sensorimotor Cortex High Frequency Oscillations Characterize Motor Symptom Severity during Deep Brain Stimulation Surgery for Parkinson's Disease.
   Ann Neurol. 2025 Oct 31. doi: 10.1002/ana.78077.
   PubMed         Abstract available
   
   
2. LI Y, Tang F, Tang B, Qiu J, et al
   Reply to "Biallelic Variants in EPG5 Gene Are Associated With Parkinson's Disease".
   Ann Neurol. 2025 Oct 29. doi: 10.1002/ana.78080.
   PubMed        
   
   
3. DAFSARI HS, Deneubourg C, Singh K, Maroofian R, et al
   Letter Concerning Biallelic Variants in EPG5 Gene Are Associated with Parkinson's Disease.
   Ann Neurol. 2025 Oct 29. doi: 10.1002/ana.78081.
   PubMed        
   
   

   
   BMC Neurol

4. ZHU Z, Geng Y, Wang X, Shi J, et al
   Characteristics of brain glucose metabolism in Parkinson's disease patients with freezing of gait: a study based on (18)F-FDG PET imaging and deep learning.
   BMC Neurol. 2025;25:446.
   PubMed         Abstract available
   
   

   
   Exp Neurol

5. NAIDJI C, Katrib C, Devos D, Durieux N, et al
   Histo-radiological correlations in an early-stage model of a Parkinson's disease.
   Exp Neurol. 2025 Oct 29:115538. doi: 10.1016/j.expneurol.2025.115538.
   PubMed         Abstract available
   
   
6. SUN W, Wei J, Lin Z, Jiang C, et al
   An involvement of ribonuclease L in Parkinson's disease via modulating the Th17/Treg balance by microRNA-7.
   Exp Neurol. 2025;396:115517.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

7. ARORA C, Kamble N, Holla VV, Mahale R, et al
   The prevalence of gastrointestinal dysfunction and its impact on quality of life in Parkinson's disease.
   J Neural Transm (Vienna). 2025 Oct 31. doi: 10.1007/s00702-025-03038.
   PubMed         Abstract available
   
   
8. SANTOS-LOBATO BL, Schuh AFS, Mata IF
   Household herbicide use is associated with the risk of Parkinson's disease and a younger age at onset in PPMI and Fox Insight cohorts.
   J Neural Transm (Vienna). 2025 Oct 31. doi: 10.1007/s00702-025-03041.
   PubMed         Abstract available
   
   
9. SANTOS L, Burtscher J, de Taboada L
   Parkinson's disease, aerobic exercise and photobiomodulation: a randomised controlled trial.
   J Neural Transm (Vienna). 2025 Oct 31. doi: 10.1007/s00702-025-03050.
   PubMed         Abstract available
   
   
10. HIRAYAMA M, Maeda T, Kashihara K, Tsuboi Y, et al
    Linking diet, gut microbiota, and metabolites to Parkinson's disease risk: a shotgun metagenomic comparison of Japanese and Taiwanese cohorts.
    J Neural Transm (Vienna). 2025 Oct 28. doi: 10.1007/s00702-025-03052.
    PubMed         Abstract available
    
    

    
    Mov Disord

11. ZHANG D, Luo L, Li L, Yao J, et al
    Glymphatic Dysfunction in Non-Manifesting Carriers of LRRK2 and GBA Pathogenic Variants.
    Mov Disord. 2025;40:2189-2198.
    PubMed         Abstract available
    
    
12. GRAYBIEL AM
    Surprises From the Basal Ganglia: Stop and Go Have New Meaning.
    Mov Disord. 2025;40:2077-2082.
    PubMed         Abstract available
    
    
13. WU Z, Zhu S, Hong R, Zhang Z, et al
    A Network Centered on the Visual-Motor Cortex Is Critically Involved in Postural Abnormality in Parkinson's Disease.
    Mov Disord. 2025 Oct 23. doi: 10.1002/mds.70088.
    PubMed         Abstract available
    
    
14. HU Z, Wan JJ, Yan QQ, Fan Y, et al
    Further Investigation of Catechol-O-Methyltransferase Gene and Parkinson's Disease Susceptibility in the UK Biobank Cohort.
    Mov Disord. 2025 Oct 27. doi: 10.1002/mds.70098.
    PubMed        
    
    
15. ALAM MS, Yu L, Stebbins GT, Mestre TA, et al
    Longitudinal Evaluation of an Abbreviated Patient-Reported Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) for Predicting Dopaminergic Therapy Initiation in Early Parkinson's Disease.
    Mov Disord. 2025 Oct 27. doi: 10.1002/mds.70096.
    PubMed         Abstract available
    
    
16. HOGLINGER G, Lingor P, Hollerhage M, Trenkwalder C, et al
    Treatment Options for Motor Fluctuations in Parkinson's Disease.
    Mov Disord. 2025 Oct 28. doi: 10.1002/mds.70107.
    PubMed        
    
    
17. DE BIE RMA, Katzenschlager R, Bruno V, Sampaio C, et al
    Reply: "Treatment Options for Motor Fluctuations in Parkinson's Disease".
    Mov Disord. 2025 Oct 28. doi: 10.1002/mds.70109.
    PubMed        
    
    
18. RACHAO A, Silva A, Prada L, Pona-Ferreira J, et al
    Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal.
    Mov Disord. 2025 Oct 30. doi: 10.1002/mds.70108.
    PubMed        
    
    
19. XIE T, Bloom L, McCracken E
    Comments on "Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets".
    Mov Disord. 2025 Nov 1. doi: 10.1002/mds.70113.
    PubMed        
    
    
20. HIRSCHWALD J, Warnecke T
    Reply to "Comments on 'Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets'".
    Mov Disord. 2025 Nov 1. doi: 10.1002/mds.70112.
    PubMed        
    
    

    
    Neurobiol Dis

21. MIZUTANI Y, Nawashiro K, Ito S, Nakai T, et al
    Elevated TFEB expression with limited activation in peripheral blood mononuclear cells reflects altered lysosomal enzyme dynamics in Parkinson's disease.
    Neurobiol Dis. 2025;217:107151.
    PubMed         Abstract available
    
    

    
    Neurochem Res

22. MANCA E, Corsi S, Fanni S, Noli B, et al
    Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression.
    Neurochem Res. 2025;50:344.
    PubMed         Abstract available
    
    

    
    PLoS One

23. NAYAN NM, Rana AM, Islam MM, Uddin J, et al
    An interpretable and balanced machine learning framework for Parkinson's disease prediction using feature engineering and explainable AI.
    PLoS One. 2025;20:e0333418.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.